Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 1,076 | 1,376 | 1,586 | 903 | 1,007 |
| Cost of Goods | 84 | 139 | 156 | 66 | 76 |
| Gross Profit | 992 | 1,237 | 1,430 | 837 | 932 |
| Operating Expenses | 21,127 | 16,998 | 15,876 | 9,865 | 8,552 |
| Operating Income | -20,050 | -15,622 | -14,290 | -8,961 | -7,545 |
| Other Income | -7 | 171 | 3 | 20 | 12 |
| Pre-tax Income | -20,057 | -15,451 | -14,287 | -8,942 | -7,533 |
| Net Income Continuous | -20,057 | -15,451 | -14,287 | -8,942 | -7,533 |
| Net Income | $-20,057 | $-15,451 | $-14,287 | $-8,942 | $-7,533 |
| EPS Basic Total Ops | -1.23 | -1.83 | -2.24 | -5.60 | -6.97 |
| EPS Basic Continuous Ops | -1.23 | -1.83 | -2.24 | -5.59 | -6.96 |
| EPS Diluted Total Ops | -1.23 | -1.83 | -2.24 | -5.60 | -6.97 |
| EPS Diluted Continuous Ops | -1.23 | -1.83 | -2.24 | -5.59 | -6.96 |
| EPS Diluted Before Non-Recurring Items | -1.23 | -1.83 | -2.24 | -5.60 | N/A |
| EBITDA(a) | $-20,031 | $-15,602 | $-14,273 | $-8,949 | $-7,539 |